Monocyte Phenotypes and Physical Activity in Patients with Carotid Atherosclerosis.

GPAQ atherosclerosis cytometry inflammation monocytes physical activity

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
05 Aug 2022
Historique:
received: 13 07 2022
revised: 01 08 2022
accepted: 03 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Atherosclerosis is associated with low-grade inflammation involving circulating monocytes. It has been shown that the levels of intermediate pro-inflammatory monocytes are associated with cardiovascular mortality and risk of ischemic stroke. It also has been shown that physical activity (PA) decreases inflammation markers, incidence of strokes, and mortality. In this cross-sectional study, we tested the effect of PA on circulating monocytes phenotype rate. A total of 29 patients with a carotid stenosis > 50% were recruited. Levels of physical activity (MET.min/week) were measured by the GPAQ questionnaire, arterial samples of blood were collected to analyze monocyte phenotype (classical, intermediate and non-classical) assessed by flow cytometry, and venous blood samples were used to dose antioxidant activity and oxidative damage. Antioxidant capacity was reduced and oxidative damage increased in patients. There was a significant decrease in the percentage of classical and intermediate monocytes in moderately active patients as compared with non-active and highly active patients. Inversely, the rate of non-classical monocytes increased in moderately active patients. Intense PA appears to blunt the beneficial effects of moderate PA. Our study also suggests that PA could be beneficial in such patients by reducing the rate of intermediate monocytes known to predict the risk of ischemic stroke and by increasing the non-classical monocytes involved in lesions’ healing. Nevertheless, a longitudinal study would be necessary to confirm this hypothesis.

Identifiants

pubmed: 36009247
pii: antiox11081529
doi: 10.3390/antiox11081529
pmc: PMC9404804
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

JAMA. 1999 May 12;281(18):1722-7
pubmed: 10328073
Thromb Haemost. 2016 Apr;115(4):762-72
pubmed: 26676845
Eur J Clin Nutr. 2015 Sep;69(9):977-1003
pubmed: 25711954
Basic Res Cardiol. 2011 Sep;106(5):749-60
pubmed: 21611880
Nature. 2002 Dec 19-26;420(6917):868-74
pubmed: 12490960
Br J Sports Med. 2008 Jan;42(1):11-5
pubmed: 17504785
Physiol Genomics. 2011 Jul 27;43(14):895-902
pubmed: 21610086
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):23-8
pubmed: 14525794
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Physiol Rev. 2006 Apr;86(2):515-81
pubmed: 16601268
Anal Biochem. 1988 Oct;174(1):331-6
pubmed: 3064653
Anal Biochem. 1971 Nov;44(1):276-87
pubmed: 4943714
Brain Behav Immun. 2005 Sep;19(5):389-97
pubmed: 15963685
JAMA. 1993 May 12;269(18):2386-91
pubmed: 8479064
J Leukoc Biol. 2008 Nov;84(5):1271-8
pubmed: 18664531
Pathophysiology. 2006 Aug;13(3):129-42
pubmed: 16757157
J Physiol. 2016 Sep 15;594(18):5081-92
pubmed: 26893258
J Lab Clin Med. 1967 Jul;70(1):158-69
pubmed: 6066618
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1506-16
pubmed: 21677293
J Am Heart Assoc. 2018 Nov 6;7(21):e009305
pubmed: 30376749
Br J Sports Med. 2020 Apr;54(8):469-474
pubmed: 30842104
Nat Rev Immunol. 2006 Jul;6(7):508-19
pubmed: 16778830
Lancet Glob Health. 2020 May;8(5):e721-e729
pubmed: 32353319
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1120-6
pubmed: 23640492
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Clin Sci (Lond). 2011 May;120(9):357-75
pubmed: 21244363
Thromb Haemost. 2011 Nov;106(5):757-62
pubmed: 21901241
Exp Physiol. 2019 Sep;104(9):1343-1352
pubmed: 31264265
Sports Med. 2018 Dec;48(12):2725-2741
pubmed: 30302720
Antioxidants (Basel). 2018 Dec 19;7(12):
pubmed: 30572572
Thromb Haemost. 2016 Sep 27;116(4):626-37
pubmed: 27412877
J Phys Act Health. 2009 Nov;6(6):790-804
pubmed: 20101923
Front Immunol. 2019 Jan 22;9:3155
pubmed: 30723479
Sports Med. 2001 Feb;31(2):115-44
pubmed: 11227979
Inflammation. 2012 Aug;35(4):1567-84
pubmed: 22556042
Atherosclerosis. 2012 Dec;225(2):461-8
pubmed: 23078881
Mediators Inflamm. 2019 Apr 4;2019:7434376
pubmed: 31089324
Demogr Res. 2014;30:795-822
pubmed: 25580082
Kidney Int. 1996 May;49(5):1304-13
pubmed: 8731095
J Appl Physiol (1985). 2005 Apr;98(4):1154-62
pubmed: 15772055
JAMA Intern Med. 2015 Jun;175(6):959-67
pubmed: 25844730
Acta Physiol (Oxf). 2015 Mar;213(3):539-53
pubmed: 25515699
Eur J Clin Nutr. 2006 Dec;60(12):1345-54
pubmed: 16788711
J Am Coll Cardiol. 2014 Jan 7-14;63(1):1-11
pubmed: 24140662
J Am Coll Cardiol. 2005 May 17;45(10):1563-9
pubmed: 15893167
Hypertension. 2009 Nov;54(5):1014-20
pubmed: 19786647
Presse Med. 2013 Jul-Aug;42(7-8):e245-58
pubmed: 23490635
Cells. 2020 Dec 24;10(1):
pubmed: 33374145
Circulation. 2002 Mar 5;105(9):1135-43
pubmed: 11877368
J Phys Act Health. 2010 Nov;7(6):697-705
pubmed: 21088299
Nat Rev Cardiol. 2011 Oct 11;9(2):116-24
pubmed: 21989048
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):206-12
pubmed: 25359858

Auteurs

Mathilde Mura (M)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Michèle Weiss-Gayet (M)

Institut NeuroMyoGene, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Nellie Della-Schiava (N)

Department of Vascular and Endovascular Surgery, Louis Pradel Hospital, 69008 Lyon, France.

Erica Chirico (E)

Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.

Patrick Lermusiaux (P)

Department of Vascular and Endovascular Surgery, Louis Pradel Hospital, 69008 Lyon, France.

Marie Chambion-Diaz (M)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Camille Faes (C)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Anaelle Boreau (A)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Bénédicte Chazaud (B)

Institut NeuroMyoGene, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Antoine Millon (A)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.
Department of Vascular and Endovascular Surgery, Louis Pradel Hospital, 69008 Lyon, France.

Vincent Pialoux (V)

Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.
Institut Universitaire de France, 75000 Paris, France.

Classifications MeSH